Switch theme
Sign up to access all valuation multiples
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injuries. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United States and four European markets: Germany, France, the UK, and the Netherlands to create a customer base.
2015
108
LTM Revenue $3.3M
LTM EBITDA -$43.2M
$171M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Onward Medical has a last 12-month revenue of $3.3M and a last 12-month EBITDA of -$43.2M.
In the most recent fiscal year, Onward Medical achieved revenue of n/a and an EBITDA of -$36.5M.
Onward Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Onward Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | XXX | XXX | XXX |
| Gross Profit | -$4.3M | -$15.8M | XXX | XXX | XXX |
| Gross Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| EBITDA | -$33.6M | -$36.5M | XXX | XXX | XXX |
| EBITDA Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Profit | -$36.9M | -$35.2M | XXX | XXX | XXX |
| Net Margin | -Infinity% | -Infinity% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Onward Medical's stock price is EUR 4 (or $4).
Onward Medical has current market cap of EUR 174M (or $187M), and EV of EUR 159M (or $171M).
See Onward Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $171M | $187M | XXX | XXX | XXX | XXX | $-1.20 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Onward Medical has market cap of $187M and EV of $171M.
Onward Medical's trades at 51.4x LTM EV/Revenue multiple, and -3.9x LTM EBITDA.
Analysts estimate Onward Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Onward Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $171M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | -4.7x | XXX | XXX | XXX |
| P/E | -4.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -4.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpOnward Medical's NTM/LTM revenue growth is 323%
Onward Medical's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.4M for the same period.
Over next 12 months, Onward Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Onward Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Onward Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | n/a | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Onward Medical acquired XXX companies to date.
Last acquisition by Onward Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Onward Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Onward Medical founded? | Onward Medical was founded in 2015. |
| Where is Onward Medical headquartered? | Onward Medical is headquartered in Belgium. |
| How many employees does Onward Medical have? | As of today, Onward Medical has 108 employees. |
| Who is the CEO of Onward Medical? | Onward Medical's CEO is Mr. Dave Marver. |
| Is Onward Medical publicy listed? | Yes, Onward Medical is a public company listed on BRU. |
| What is the stock symbol of Onward Medical? | Onward Medical trades under ONWD ticker. |
| When did Onward Medical go public? | Onward Medical went public in 2021. |
| Who are competitors of Onward Medical? | Similar companies to Onward Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Onward Medical? | Onward Medical's current market cap is $187M |
| What is the current revenue of Onward Medical? | Onward Medical's last 12-month revenue is $3.3M. |
| What is the current EBITDA of Onward Medical? | Onward Medical's last 12-month EBITDA is -$43.2M. |
| What is the current EV/Revenue multiple of Onward Medical? | Current revenue multiple of Onward Medical is 51.4x. |
| What is the current EV/EBITDA multiple of Onward Medical? | Current EBITDA multiple of Onward Medical is -3.9x. |
| Is Onward Medical profitable? | Yes, Onward Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
